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Objectives: Triptolide (TP), a natural extract from Tripterygium wilfordii
has been applied extensively for treating glomerularsclerosis (GS) in patients
with early diabetic nephropathy (DN) in China. Activation of mTOR plays a
critical role in pathologic forms of hypertrophy and proliferation in kidneys
under hyperglycemia other than classical TGF-beta1/Smad pathway. Hyper-
glycemia increases mTOR activity by combined actions of Akt activation and
AMPK inhibition. This study aimed to investigate effects and mechanisms of
TP on GS, compared with rapamycin through regulating Akt/AMPK/mTOR or
TGF-beta1/Smad signaling activities.
Methods: Rats were randomly divided into 4 groups, sham-operated group, TP-
treated group, vehicle-given group and rapamycin-treated group, and sacri-
ficedatweek8after inductionofDNby2 consecutive intraperitoneal injections
of streptozotocin (STZ)with an interval of 1week following nephrectomy. Daily
oral administration of TP, rapamycin and saline were started after the second
injection of STZ until the sacrifice. Proteinuria, UAlb, BG, biochemical indica-
tors, renal pathological changes, as well as key protein expressions in Akt/
AMPK/mTOR and TGF-beta1/Smad pathways in kidneys were examined,
respectively. An experiment in glomerular mesangial cells was performed to
examine effects of TP on cellular proliferation and collagen synthesis.
Results: Akt/AMPK/mTOR and TGF-beta1/Smad pathways were concurrently
activated in kidneys. TP, similar to rapamycin, regulated protein expressions
of p-Akt, p-mTOR,p-p70S6K, p-Smad2/3 andTGF-beta1 in kidneys, andamelio-
rated proteinuria, mesangial matrix expansion, alpha-SMA expression and
collagen deposition in glomeruli, without lowering hyperglycemia. Addition-
ally, retardation in glomerularsclerotic development was observed. In HBZY-1
cell line, TP, analogous to rapamycin, decreased high-glucose-induced cell pro-
liferation and expressions of TGF-beta1, p-Smad2/3 and collagen IV.
Conclusion: Activated Akt/AMPK/mTOR and TGF-beta1/Smad pathways
jointly contribute to glomerular injury. TP, as a natural regulator, effectively
attenuate GS by potential molecular mechanisms involving reduction of
mesangial matrix and suppression of Akt and mTOR activation, as well as
regulation of TGF-beta1/Smad signaling activity.http://dx.doi.org/10.1016/j.hkjn.2015.08.005
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Objectives: Total flavone glycosides of flos abelmoschus manihot (TFA) has
been widely used for treating renal fibrosis in patients with diabetic ne-
phropathy (DN) in China. However, therapeutic mechanisms remain unclear.
Oxidative stress (OS) is a determinant during renal fibrotic progress under
hyperglycemia. As one of the regulative approaches of OS, p38MAPK
signaling pathway plays a pivotal role. This study thereby aimed to investi-
gate effects and mechanisms in vivo of TFA on renal fibrosis, compared
with alpha-lipoic acid (ALA) as an antioxidant in clinic, through attenuating
OS-related injury and p38MAPK signaling activity.
Methods: Rats were randomly divided into 5 groups, sham-operated group,
vehicle-given group, low dose of TFA-treated group, high dose of TFA-
treated group and ALA-treated group. TFA, ALA and saline were daily admin-
istrated for 8 weeks after induction of DN by streptozotocin (STZ) with uni-
lateral nephrectomy. The DN rats’ general state, biochemical indicators,
renal pathological changes, OS-related markers, as well as key protein ex-
pressions in p38MAPK signaling pathway, fibrogenic cytokines and inflamma-
tory factors were examined, respectively.
Results: DNmodel rats exhibited typical renal fibrosis, OS-related features and
increases in expressions of p-p38MAPK, TGF-b1 and TNF-a. UAlb, BUN, UA, Alb,
TG, TC and OS-related markers including MDA, T-SOD, GSH-Px, 8-OHdG and
NOX4 in serum or kidneys were ameliorated in treated groups, especially in
high dose of TFA-treated group. Of note, TFA synchronously inhibited
p38MAPK signaling activity and TGF-b1 and TNF-a protein overexpressions,
whereas, ALA only suppressed TNF-a protein overexpression in kidneys.
Conclusion: By means of the DN model rats, we demonstrated that OS pro-
motes renal fibrosis and p38MAPK signaling activity. TFA, as a natural regulator
in vivo, can improve OS-related renal damage via regulating protein overex-
pressions of p-p38MAPK, TGF-b1 and TNF-a, which is different from ALA.http://dx.doi.org/10.1016/j.hkjn.2015.08.006
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Objective: To study the influence of the deposition of complement 3 on the
prognosis of nodular sclerosis of diabetic nephropathy.
Methods: Clinical and pathological materials were collected from 89 pa-
tients who suffered from nodular sclerosis of diabetic nephropathy proved
by renal biopsy and took Angiotensin-Converting Enzyme Inhibitors or
